| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Septerna, Inc. | Director | Common Stock | 117K | $813K | $6.93 | 07 Mar 2025 | Direct |
| Organon & Co. | Director | Phantom Stock | 62.7K | $630K | $10.04 | 13 Jun 2025 | Direct |
| Fulcrum Therapeutics, Inc. | Director | Stock Option (right to buy) | 36K | 26 Jun 2025 | Direct | ||
| Septerna, Inc. | Director | Stock Option (Right to Buy) | 16.6K | 17 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 16:15 |
| SEPN | Septerna, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 18:36 |
| OGN | Organon & Co. | 13 Jun 2025 | 1 | $240K | 4 | Director | 16 Jun 2025, 17:21 |
| SEPN | Septerna, Inc. | 07 Mar 2025 | 1 | $92.3K | 4 | Director | 10 Mar 2025, 16:18 |
| SEPN | Septerna, Inc. | 04 Mar 2025 | 3 | $516K | 4 | Director | 06 Mar 2025, 21:02 |
| SEPN | Septerna, Inc. | 24 Oct 2024 | 0 | $0 | 3 | Director | 24 Oct 2024, 21:28 |
| FULC | Fulcrum Therapeutics, Inc. | 17 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:20 |
| OGN | Organon & Co. | 07 Jun 2024 | 1 | $200K | 4 | Director | 11 Jun 2024, 15:17 |
| FULC | Fulcrum Therapeutics, Inc. | 27 Jun 2023 | 1 | $0 | 4 | Director | 29 Jun 2023, 16:16 |
| OGN | Organon & Co. | 09 Jun 2023 | 1 | $200K | 4 | Director | 13 Jun 2023, 16:51 |
| FULC | Fulcrum Therapeutics, Inc. | 27 Jun 2022 | 2 | $0 | 4 | Director | 29 Jun 2022, 17:00 |
| OGN | Organon & Co. | 10 Jun 2022 | 1 | $200K | 4 | Director | 14 Jun 2022, 19:32 |
| FULC | Fulcrum Therapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 17:10 |
| OGN | Organon & Co. | 04 Jun 2021 | 1 | $316K | 4 | Director | 08 Jun 2021, 20:39 |
| OGN | Organon & Co. | 02 Jun 2021 | 0 | $0 | 3 | Director | 02 Jun 2021, 17:54 |